SCHEMBL4091751

SCHEMBL4091751

Cc1ccc(C)c(S(=O)(=O)Cl)c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP2 O95551 1/20 0.39
▸ NSD2 O96028 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ PAX8 Q06710 1/20 0.39
▸ TDP1 Q9NUW8 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ KEAP1 Q14145 1/20 0.33
▸ NFE2L2 Q16236 1/20 0.33
▸ LMNA P02545 2/20 0.32
▸ GAA P10253 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ CYP19A1 P11511 1/20 0.32
▸ TSHR P16473 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ RAPGEF4 Q8WZA2 1/20 0.30
▸ CYP1A2 P05177 2/20 0.30
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2266737 0.84 TRPV4 (0.36) TDP2NSD2HSP90AA1PAX8TDP1
SCHEMBL8654404 0.79 TDP2 (0.42) TDP2NSD2HSP90AA1PAX8TDP1
SCHEMBL9522846 0.78 ALDH1A1 (0.42) TDP1ALDH1A1HSD17B10LMNAMEN1
SCHEMBL1500713 0.77 ALDH1A1 (0.40) TDP1ALDH1A1HSD17B10KEAP1NFE2L2
SCHEMBL1021882 0.77 KMT2A (0.44) TDP1ALDH1A1HSD17B10LMNAGAA
SCHEMBL2263745 0.77 RAPGEF4 (0.40) LMNAGAAMAPK1HTTCYP19A1
SCHEMBL29451557 0.76 TSHR (0.47) TDP1ALDH1A1HSD17B10GAATSHR
SCHEMBL10538992 0.76 TSHR (0.47) TDP1ALDH1A1HSD17B10GAATSHR
SCHEMBL8764002 0.76 TSHR (0.47) TDP1ALDH1A1HSD17B10LMNAGAA
SCHEMBL2929807 0.75 CA2 (0.41) TDP2NSD2HSP90AA1PAX8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263598-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2012-09-11 — — US disclosed
US-20090186899-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-07-23 — — US disclosed
EP-0078498-B1 METHOD FOR PROTECTING AMINO GROUP AND RESTORING THE SAME Takeda Chemical Industries, Ltd. (JP) 1986-01-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186899-A1 Substituted Sulfonamide Compounds BDKRB1, BDKRB2, NPSR1 TDP2 4406/4885NSD2 1015/4885HSP90AA1 3101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback